| Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 203.14 crore and a net loss of Rs 46.87 crore for the quarter ended Sep '14. | | For the quarter ended Sep 2013 the consolidated total income from operations was Rs 272.76 crore and net profit was Rs 3.14 crore. | | Elder Pharma shares closed at 132.30 on December 12, 2014 (NSE) and has given -40.58% returns over the last 6 months and -59.30% over the last 12 months. |
|
| | Elder Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Sep '14 | Jun '14 | | | Sep '13 | | Net Sales/Income from operations | 200.31 | 122.83 | | | 271.68 | | Other Operating Income | 2.83 | -2.61 | | | 1.08 | | Total Income From Operations | 203.14 | 120.23 | | | 272.76 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 10.63 | 9.48 | | | 12.69 | | Purchase of Traded Goods | 125.85 | 60.93 | | | 100.51 | | Increase/Decrease in Stocks | -3.02 | 105.93 | | | 21.23 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 44.91 | 39.54 | | | 48.77 | | Depreciation | 11.32 | 6.30 | | | 9.22 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 50.34 | 52.51 | | | 45.55 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -36.90 | -154.47 | | | 34.78 | | Other Income | 9.32 | 2.12 | | | 6.44 | | P/L Before Int., Excpt. Items & Tax | -27.57 | -152.34 | | | 41.22 | | Interest | 23.18 | 120.01 | | | 36.81 | | P/L Before Exceptional Items & Tax | -50.76 | -272.35 | | | 4.40 | | Exceptional Items | 4.03 | 368.85 | | | -- | | P/L Before Tax | -46.72 | 96.50 | | | 4.40 | | Tax | 0.15 | -0.05 | | | 1.26 | | P/L After Tax from Ordinary Activities | -46.87 | 96.55 | | | 3.14 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -46.87 | 96.55 | | | 3.14 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -46.87 | 96.55 | | | 3.14 | | Equity Share Capital | 20.54 | 20.54 | | | 20.54 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -22.82 | 47.01 | | | 1.53 | | Diluted EPS | -22.82 | 47.01 | | | 1.53 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -22.82 | 47.01 | | | 1.53 | | Diluted EPS | -22.82 | 47.01 | | | 1.53 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 1.48 | 1.53 | | | 1.35 | | Share Holding (%) | 72.12 | 74.74 | | | 65.87 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.45 | 0.47 | | | 0.69 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 77.73 | 89.94 | | | 99.17 | | - Per. of shares (as a % of the total Share Cap. of the company) | 21.67 | 22.72 | | | 33.84 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 0.13 | 0.05 | | | 0.01 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 22.27 | 10.06 | | | 0.83 | | - Per. of shares (as a % of the total Share Cap. of the company) | 6.21 | 2.54 | | | 0.28 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
